{"name":"Confo Therapeutics","slug":"confo-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQbE82UlRsbVJlLU5kQXRRRGRDZ3c3M3hORVg5TWNJQ3ZPZ2VDRUFGUG5uSjRSMU9DZkI0SHFIOGNmNUlXMjMtU3RPX3phcEVGZGNwZVA3dkxGdExoTlFFZ3B3TFlYRUFvR29EN0dwaWpHZDM3cVJzeVItbzBmdkRGczBMTWJVaFZlZkNQck9UMmZyVG02VHBhOERGWkxpY2RVb0xxeElUcVpWZTlVckYwTEROakJxa0JIUU5ySFFyZw?oc=5","date":"2026-01-22","type":"pipeline","source":"bloomberg.com","summary":"Llamas Are Big Pharma’s Secret Weapon to Find New Drugs - bloomberg.com","headline":"Llamas Are Big Pharma’s Secret Weapon to Find New Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPVkdZWEVVaG9qaWtUSlBQbEphOXNOOWVTdVJCQThscld0SGhmSjJEUWVCUVBoOWdDc0lBVmhxRWZjUWp5ZzdyY0h4N0lJSU1ESFBhQ0htSm1hNHE0OTA4RlJ0Yzd2YVRWNG5WbzloSFVjVXVsWkxHM2llR0VoaUhTX05aMmVpeTM3Y194VnZhdU4xTzM3SktVOERXZXdidEc1WXhZZGR3?oc=5","date":"2025-10-30","type":"pipeline","source":"Fierce Biotech","summary":"Eli Lilly sidelines midstage prospect in another pain pipeline pivot - Fierce Biotech","headline":"Eli Lilly sidelines midstage prospect in another pain pipeline pivot","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE9rdXBlMVlMZnByd3ItT1F4Q1pqWUFNbGhMZ0dWTFlWc2tFSHNhNS05eG5Ed0VENmJPbGgyMTJiOGxFdTdPNVFnNWl5UHlTVy1PT1dpdVkxbW12b0NSemgzWEY5TVVmYXNUaEoyZUtHdDhHdw?oc=5","date":"2025-10-28","type":"pipeline","source":"Labiotech.eu","summary":"Meet 7 promising Belgian biotech companies set to make waves in 2025 - Labiotech.eu","headline":"Meet 7 promising Belgian biotech companies set to make waves in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQTjlfX0NCTDE5SXZaMXh3dTM0c3lUa3ZySEhodlFiMHJOOGg4VDhSMXNWUDkzdlN2MWJ5UFg2N1kyd1RGNUNmUExZSkt4UkYtTXFMQlZ5bHpTa2dTeFljeEo2RW5aMXBFVWV0SDdsUW9IUGJHMUtOMXpjZ3lwU1R6V0hkNmhuaWhhUWJPZXdKd1AyTGdXNTRwRkRpMW1HVHpVY3hheFI4cHVGWXd0Smsya1lR?oc=5","date":"2025-05-27","type":"deal","source":"Reuters","summary":"Eli Lilly to buy SiteOne for $1 billion with eye on non-opioid pain drug - Reuters","headline":"Eli Lilly to buy SiteOne for $1 billion with eye on non-opioid pain drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOUGl5WFQ3dHpxazY2T0NTWDdCbWN2bDlxZFVWaFh3Um52bUJGbzRTVnFhSEplYk5WaHFidDZGMngxend4cFBZbncyWWhwekkyWV9sMjdYbENKV1JnbnRPRmtnYTZ2dkFTUGkzZGRRQ3NvTzNRLUlsZzRfUUFKZFg0eWV1MXpLeURQMXVxRFMwaXJYRGY1QXlj?oc=5","date":"2024-10-29","type":"pipeline","source":"Labiotech.eu","summary":"GPCR therapies: Eight promising biotechs hacking the cell signaling pathway - Labiotech.eu","headline":"GPCR therapies: Eight promising biotechs hacking the cell signaling pathway","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE8yYWpDNHhSSUhaelNpZTM3WTh2cFVDcDc4RlFTcXA3OG1nRFVHZmFETmNhVEJYYWtkSjZGaktsS1ZaTGlWR2YzM3BGV1dDY0syYjVJbklWNW9QTHhITXV2TA?oc=5","date":"2024-07-01","type":"pipeline","source":"The Pharma Letter","summary":"Confo Therapeutics - The Pharma Letter","headline":"Confo Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9CaTFtMTlNWVhRYzdTNl96M1NVejZvZVdkMlJNc19vZDlBYUVMeGNSMFh5ZzRndkZSVTUwb1FtTi16NjdHLVRYUWRDamhqbjlrWkVTQnptVF92Q2pxYzlJV2hWRlZhWkhuekE?oc=5","date":"2023-10-05","type":"pipeline","source":"pharmatimes.com","summary":"Stephen Dowd - pharmatimes.com","headline":"Stephen Dowd","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQMzRMUFBOSGtYVFh1V0FDSWd2YnBPZmhZTmNfQmNFRHN2X21VRUtNLUo3cGVwLWdWc05TX29DeGk1RHlld01zRXRIc2M3U2lxSmc0TW1fRDl2bGdVeklhSEhvNW9Db2w2ZGRMV2ZsN05XWjJGT1J0VnRzamUxU1NkWnhR?oc=5","date":"2023-03-03","type":"deal","source":"pharmaphorum","summary":"Lilly adds to non-opioid pain pipeline with Confo deal - pharmaphorum","headline":"Lilly adds to non-opioid pain pipeline with Confo deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPZXRINno0enBNTGRvWkRyMVlZeVJNbWFnX3JXV0tnWWU3STc0Rkt6WFgxZVl6c1Z3TVBzcnZVdHY4TWZaSE9jc3JJZ3JUQUZSNXlEemt6X3VuSkJZaU1SaHBEQ2VZemp0SnJ1RHRJeVRqS1pnWFoxRTR2aWZoejZKWE5vZVlHVGl6azVlWW14Z0dRSWpZZXZMZ19WQTJOel84ejY5QjFxdlVhVTVLQW5LU1BMVFU?oc=5","date":"2023-03-03","type":"deal","source":"Pharmafile","summary":"Eli Lilly signs $40m licensing deal with Confo Therapeutics over neuropathic pain treatment - Pharmafile","headline":"Eli Lilly signs $40m licensing deal with Confo Therapeutics over neuropathic pain treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOaWRROVlVb1E5OGI0RkUxWFJrMEVGSkNHT240aGNzb29aeVJHSmFVanVpZDhab0o1SFoxa2w2RXVhMy1jUkhxUmN1d1dZdW1CV0l3cS12c2tRYjdYRXVlUmQzNzN5U0lhSWNZSVFUa3kwaDlKWjhhVm1nUEZ1MUY4Tk1WbDI4TWNEZThtUzhGOHV3Zk1RT2ltSUR5SFlnWW8wb0VQbEt5WEU?oc=5","date":"2023-03-02","type":"deal","source":"European Biotechnology Magazine","summary":"Confo Therapeutics and Lilly partner to advance CFTX-1554 - European Biotechnology Magazine","headline":"Confo Therapeutics and Lilly partner to advance CFTX-1554","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQanNvVG12XzJ3V3BXdnBXVGdzRlZGQXdILVNtMkZxMFoxWVFVdjJDcDFIMWhjZm53cVhZVVFBeHktelJEeXlfX04wSTd1VjJodHNjMHFwWjlPcHlvTTEzcHJTejhlbkxTU3E2cUdNRkQ3Y2FnZWFRc1hjcTF6dTJTVWFYeVRkYnd4RlRRNXRZUEQxRGxDeGZzem9n?oc=5","date":"2023-03-02","type":"deal","source":"Fierce Biotech","summary":"Confo hands baton to Lilly for non-opioid pain med development in $40M upfront deal - Fierce Biotech","headline":"Confo hands baton to Lilly for non-opioid pain med development in $40M upfront deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQV1h3T2lISjZ2Z19xR29Ibi0zaDdVY1E0ejlvekVYOXMwSWVHWEpVQkhKX2xoMGJ4alJkMHk0bDh0R2ZwNzJiN0lpWTNHWUVZRVBYUmpyeDZieGNiY1hoWGRlZlZGYUVvS0FNSTRMcWplOFUzMjlOeWNrTXV4ZzNpOHJlMXBXZ0VYdE9mRXNwZHQyQzBoakNxX0c5cWNWTEdLdlctNkJJSVlUVDU2cnA2X3RzWnY2SWs3SFZJamNTWTlDOTRM?oc=5","date":"2017-12-19","type":"deal","source":"PR Newswire","summary":"Confo Therapeutics Enters Into Drug Discovery Collaboration with Roche - PR Newswire","headline":"Confo Therapeutics Enters Into Drug Discovery Collaboration with Roche","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}